欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
MYCi975_2289691-01-4_产品详情
2289691-01-4
  • names:

    MYCi975

  • CAS号:

    2289691-01-4

    MDL Number:
  • MF(分子式): C25H16Cl2F6N2O2 MW(分子量): 561.3
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
MYCi975
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001658-5mg 10mg 99% ¥ 7410.00 ¥ 7410.00 2-3天
- +
¥ 0.00
YZM001658-1mg 5mg 99% ¥ 4550.00 ¥ 4550.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 2289691-01-4
Inchi
InchiKey
分子式 Formula C25H16Cl2F6N2O2
分子量 Molecular Weight 561.3
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
MYCi975(CAS:2289691-01-4)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 MYCi975 (NUCC-0200975) 是一种有效的具有口服活性的MYC抑制剂,它破坏 MYC/MAX 相互作用,促进 MYC T58 磷酸化和 MYC 降解,并损害 MYC 驱动的基因表达
IntroductionMYCi975 (NUCC200975) is an orally activeMYCinhibitor, which disrupts MYC/MAX interaction, promotes MYC T58 phosphorylation and MYC degradation, and impairs MYC driven gene expression. MYCi975 (NUCC200975) exhibits potent antiumor efficacy with good tolerability, increases tumor immune cell infiltration, and sensitizes tumors to antiD1 immunotherapy.
Application1
Application2
Application3
MYCi975 (NUCC-0200975) 是一种有效的具有口服活性的MYC抑制剂,它破坏 MYC/MAX 相互作用,促进 MYC T58 磷酸化和 MYC 降解,并损害 MYC 驱动的基因表达。MYCi975 (NUCC-0200975) 具有很强的抗肿瘤作用和良好的耐受性,增加肿瘤免疫细胞浸润,增强肿瘤对抗 PD1 免疫治疗的敏感性。MYCi975 (NUCC-0200975) is an orally activeMYCinhibitor, which disrupts MYC/MAX interaction, promotes MYC T58 phosphorylation and MYC degradation, and impairs MYC driven gene expression. MYCi975 (NUCC-0200975) exhibits potent anti-tumor efficacy with good tolerability, increases tumor immune cell infiltration, and sensitizes tumors to anti-PD1 immunotherapy[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Han H, et al. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell. 2019 Nov 11;36(5):483-497.e15.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents